• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

艾塞那肽-4通过抑制实验性糖尿病中的钙通道来促进视网膜神经节细胞的存活和功能。

Exendin-4 promotes retinal ganglion cell survival and function by inhibiting calcium channels in experimental diabetes.

作者信息

Wang Yong-Chen, Wang Lu, Shao Yu-Qi, Weng Shi-Jun, Yang Xiong-Li, Zhong Yong-Mei

机构信息

State Key Laboratory of Medical Neurobiology and MOE Frontiers Center for Brain Science, Institutes of Brain Science, Fudan University, 138 Yixueyuan Road, Shanghai 200032, China.

出版信息

iScience. 2023 Aug 18;26(9):107680. doi: 10.1016/j.isci.2023.107680. eCollection 2023 Sep 15.

DOI:10.1016/j.isci.2023.107680
PMID:37680468
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10481356/
Abstract

Progressive damage of retinal ganglion cells (RGCs) is observed in early diabetic retinopathy. Intracellular Ca overload mediated by Ca influx through voltage-gated Ca channels (VGCCs) is involved in neurodegeneration, whereas glucagon-like peptide-1 (GLP-1) provides neuroprotection. However, whether GLP-1 plays a neuroprotective role in diabetic retinas by modulating VGCCs remains unknown. We found that eye drops of exendin-4, a long-acting GLP-1 receptor (GLP-1R) agonist, prevented the increase of L-type Ca current () densities of RGCs induced by 4-week hyperglycemia and promoted RGC survival by suppressing L-type VGCC (L-VGCC) activity in streptozotocin-induced diabetic rats. Moreover, exendin-4-induced suppression of in RGCs may be mediated by a GLP-1R/Gs/cAMP-PKA/ryanodine/Ca/calmodulin/calcineurin/PP1 signaling pathway. Furthermore, exendin-4 functionally improved the light-evoked spiking ability of diabetic RGCs. These results suggest that GLP-1R activation enhances cAMP to PP1 signaling and that PP1 inactivates L-VGCCs by dephosphorylating them, thereby reducing Ca influx, which could protect RGCs against excitotoxic Ca overload.

摘要

在早期糖尿病视网膜病变中可观察到视网膜神经节细胞(RGCs)的进行性损伤。通过电压门控钙通道(VGCCs)内流介导的细胞内钙超载参与神经退行性变,而胰高血糖素样肽-1(GLP-1)具有神经保护作用。然而,GLP-1是否通过调节VGCCs在糖尿病视网膜中发挥神经保护作用尚不清楚。我们发现,长效GLP-1受体(GLP-1R)激动剂艾塞那肽-4滴眼液可预防4周高血糖诱导的RGCs L型钙电流()密度增加,并通过抑制链脲佐菌素诱导的糖尿病大鼠L型VGCC(L-VGCC)活性促进RGCs存活。此外,艾塞那肽-4诱导的RGCs 抑制可能由GLP-1R/Gs/cAMP-PKA/ryanodine/Ca/calmodulin/calcineurin/PP1信号通路介导。此外,艾塞那肽-4在功能上改善了糖尿病RGCs的光诱发尖峰能力。这些结果表明,GLP-1R激活增强了cAMP到PP1的信号传导,并且PP1通过使L-VGCCs去磷酸化使其失活,从而减少钙内流,这可以保护RGCs免受兴奋性毒性钙超载的影响。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8dcf/10481356/1ab474d31cb3/gr7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8dcf/10481356/87ae74e3e4a4/fx1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8dcf/10481356/188cfd00032e/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8dcf/10481356/7df28c7dd8d6/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8dcf/10481356/7a4631d91059/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8dcf/10481356/ad01b8959cb8/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8dcf/10481356/8b653c6ad6ce/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8dcf/10481356/81637fa8ffdb/gr6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8dcf/10481356/1ab474d31cb3/gr7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8dcf/10481356/87ae74e3e4a4/fx1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8dcf/10481356/188cfd00032e/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8dcf/10481356/7df28c7dd8d6/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8dcf/10481356/7a4631d91059/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8dcf/10481356/ad01b8959cb8/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8dcf/10481356/8b653c6ad6ce/gr5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8dcf/10481356/81637fa8ffdb/gr6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8dcf/10481356/1ab474d31cb3/gr7.jpg

相似文献

1
Exendin-4 promotes retinal ganglion cell survival and function by inhibiting calcium channels in experimental diabetes.艾塞那肽-4通过抑制实验性糖尿病中的钙通道来促进视网膜神经节细胞的存活和功能。
iScience. 2023 Aug 18;26(9):107680. doi: 10.1016/j.isci.2023.107680. eCollection 2023 Sep 15.
2
Sigma-1 receptor stimulation attenuates calcium influx through activated L-type Voltage Gated Calcium Channels in purified retinal ganglion cells.Sigma-1 受体刺激可减少纯化的视网膜神经节细胞中激活的 L 型电压门控钙通道的钙内流。
Exp Eye Res. 2013 Feb;107:21-31. doi: 10.1016/j.exer.2012.11.002. Epub 2012 Nov 23.
3
Topical administration of GLP-1 eyedrops improves retinal ganglion cell function by facilitating presynaptic GABA release in early experimental diabetes.在早期实验性糖尿病中,局部应用胰高血糖素样肽-1(GLP-1)滴眼液可通过促进突触前γ-氨基丁酸(GABA)释放来改善视网膜神经节细胞功能。
Neural Regen Res. 2026 Feb 1;21(2):800-810. doi: 10.4103/NRR.NRR-D-24-00001. Epub 2024 Jun 26.
4
Signaling Mechanism for Modulation by GLP-1 and Exendin-4 of GABA Receptors on Rat Retinal Ganglion Cells.GLP-1 和 Exendin-4 调制大鼠视网膜神经节细胞 GABA 受体的信号机制。
Neurosci Bull. 2022 Jun;38(6):622-636. doi: 10.1007/s12264-022-00826-9. Epub 2022 Mar 12.
5
Topical ocular administration of the GLP-1 receptor agonist liraglutide arrests hyperphosphorylated tau-triggered diabetic retinal neurodegeneration via activation of GLP-1R/Akt/GSK3β signaling.局部眼部给予 GLP-1 受体激动剂利拉鲁肽通过激活 GLP-1R/Akt/GSK3β 信号通路阻止高磷酸化 tau 触发的糖尿病性视网膜神经退行性变。
Neuropharmacology. 2019 Jul 15;153:1-12. doi: 10.1016/j.neuropharm.2019.04.018. Epub 2019 Apr 20.
6
Exendin-4 inhibits structural remodeling and improves Ca homeostasis in rats with heart failure via the GLP-1 receptor through the eNOS/cGMP/PKG pathway.艾塞那肽-4通过eNOS/cGMP/PKG途径经胰高血糖素样肽-1受体抑制心力衰竭大鼠的结构重塑并改善钙稳态。
Peptides. 2017 Apr;90:69-77. doi: 10.1016/j.peptides.2017.02.008. Epub 2017 Feb 24.
7
Activation of Glucagon-Like Peptide-1 Receptor Promotes Neuroprotection in Experimental Autoimmune Encephalomyelitis by Reducing Neuroinflammatory Responses.胰高血糖素样肽-1 受体的激活通过减轻神经炎症反应促进实验性自身免疫性脑脊髓炎的神经保护作用。
Mol Neurobiol. 2018 Apr;55(4):3007-3020. doi: 10.1007/s12035-017-0550-2. Epub 2017 Apr 29.
8
Activation of 5-HT1A Receptors Promotes Retinal Ganglion Cell Function by Inhibiting the cAMP-PKA Pathway to Modulate Presynaptic GABA Release in Chronic Glaucoma.5-HT1A 受体的激活通过抑制 cAMP-PKA 通路来调节慢性青光眼的突触前 GABA 释放,从而促进视网膜神经节细胞的功能。
J Neurosci. 2019 Feb 20;39(8):1484-1504. doi: 10.1523/JNEUROSCI.1685-18.2018. Epub 2018 Dec 12.
9
Protection of exendin-4 analogue in early experimental diabetic retinopathy.艾塞那肽-4类似物对早期实验性糖尿病视网膜病变的保护作用
Graefes Arch Clin Exp Ophthalmol. 2009 May;247(5):699-706. doi: 10.1007/s00417-008-1004-3. Epub 2008 Dec 16.
10
Hyperglycemia-induced GLP-1R downregulation causes RPE cell apoptosis.高血糖诱导的胰高血糖素样肽-1受体下调导致视网膜色素上皮细胞凋亡。
Int J Biochem Cell Biol. 2015 Feb;59:41-51. doi: 10.1016/j.biocel.2014.11.018. Epub 2014 Dec 5.

引用本文的文献

1
Understanding the risk of diabetic retinopathy from glucagon-like peptide-1 receptor agonists: a Mendelian randomization study and systematic review of European populations.基于孟德尔随机化研究及欧洲人群系统评价探究胰高血糖素样肽-1受体激动剂引发糖尿病视网膜病变的风险
Diabetol Metab Syndr. 2025 Aug 20;17(1):345. doi: 10.1186/s13098-025-01878-3.
2
Unlocking the potential of GLP-1 receptor agonists in ocular therapeutics: from molecular pathways to clinical impact.释放胰高血糖素样肽-1受体激动剂在眼科治疗中的潜力:从分子途径到临床影响。
Front Pharmacol. 2025 Jul 24;16:1618079. doi: 10.3389/fphar.2025.1618079. eCollection 2025.
3

本文引用的文献

1
Rapid Reduction of HbA1c and Early Worsening of Diabetic Retinopathy: A Real-world Population-Based Study in Subjects With Type 2 Diabetes.糖化血红蛋白快速下降与糖尿病视网膜病变的早期恶化:基于真实世界人群的 2 型糖尿病患者研究。
Diabetes Care. 2023 Sep 1;46(9):1633-1639. doi: 10.2337/dc22-2521.
2
What else can we do to prevent diabetic retinopathy?我们还能做些什么来预防糖尿病视网膜病变?
Diabetologia. 2023 Sep;66(9):1614-1621. doi: 10.1007/s00125-023-05940-5. Epub 2023 Jun 6.
3
Morpho-functional analysis of the early changes induced in retinal ganglion cells by the onset of diabetic retinopathy: The effects of a neuroprotective strategy.
Exendin-4 alleviates diabetic retinopathy by activating autophagy via regulation of the adenosine monophosphate-activated protein kinase/sirtuin 1 pathway.
艾塞那肽-4通过调节腺苷单磷酸活化蛋白激酶/沉默调节蛋白1信号通路激活自噬,从而减轻糖尿病视网膜病变。
J Mol Histol. 2025 Jun 28;56(4):210. doi: 10.1007/s10735-025-10405-7.
4
Potential mechanisms of epigenetic regulation in diabetic retinopathy from the perspectives of multi-omics.从多组学角度看糖尿病视网膜病变中表观遗传调控的潜在机制
Diabetol Metab Syndr. 2025 May 14;17(1):155. doi: 10.1186/s13098-025-01723-7.
5
Glaucomatous retinal ganglion cells: death and protection.青光眼性视网膜神经节细胞:死亡与保护
Int J Ophthalmol. 2025 Jan 18;18(1):160-167. doi: 10.18240/ijo.2025.01.20. eCollection 2025.
6
Electrophysiological evaluation of the effect of peptide toxins on voltage-gated ion channels: a scoping review on theoretical and methodological aspects with focus on the Central and South American experience.肽毒素对电压门控离子通道影响的电生理评估:聚焦中南美洲经验的理论与方法学方面的范围综述
J Venom Anim Toxins Incl Trop Dis. 2024 Sep 2;30:e20230048. doi: 10.1590/1678-9199-JVATITD-2023-0048. eCollection 2024.
7
Cell and molecular targeted therapies for diabetic retinopathy.糖尿病视网膜病变的细胞和分子靶向治疗。
Front Endocrinol (Lausanne). 2024 Jun 14;15:1416668. doi: 10.3389/fendo.2024.1416668. eCollection 2024.
8
Topical administration of GLP-1 eyedrops improves retinal ganglion cell function by facilitating presynaptic GABA release in early experimental diabetes.在早期实验性糖尿病中,局部应用胰高血糖素样肽-1(GLP-1)滴眼液可通过促进突触前γ-氨基丁酸(GABA)释放来改善视网膜神经节细胞功能。
Neural Regen Res. 2026 Feb 1;21(2):800-810. doi: 10.4103/NRR.NRR-D-24-00001. Epub 2024 Jun 26.
9
Glucagon-like peptide-1 receptor agonists rescued diabetic vascular endothelial damage through suppression of aberrant STING signaling.胰高血糖素样肽-1受体激动剂通过抑制异常的STING信号传导挽救糖尿病血管内皮损伤。
Acta Pharm Sin B. 2024 Jun;14(6):2613-2630. doi: 10.1016/j.apsb.2024.03.011. Epub 2024 Mar 10.
10
The role of neurovascular coupling dysfunction in cognitive decline of diabetes patients.神经血管耦合功能障碍在糖尿病患者认知功能下降中的作用。
Front Neurosci. 2024 Mar 21;18:1375908. doi: 10.3389/fnins.2024.1375908. eCollection 2024.
糖尿病视网膜病变发病早期诱导的视网膜神经节细胞形态功能变化分析:神经保护策略的影响。
Pharmacol Res. 2022 Nov;185:106516. doi: 10.1016/j.phrs.2022.106516. Epub 2022 Oct 19.
4
Signaling Mechanism for Modulation by GLP-1 and Exendin-4 of GABA Receptors on Rat Retinal Ganglion Cells.GLP-1 和 Exendin-4 调制大鼠视网膜神经节细胞 GABA 受体的信号机制。
Neurosci Bull. 2022 Jun;38(6):622-636. doi: 10.1007/s12264-022-00826-9. Epub 2022 Mar 12.
5
Protective effect of -huMSCs on the retina of diabetic model rats.人脐带间充质干细胞对糖尿病模型大鼠视网膜的保护作用。
Int J Ophthalmol. 2021 Oct 18;14(10):1508-1517. doi: 10.18240/ijo.2021.10.06. eCollection 2021.
6
Safety of Semaglutide.司美格鲁肽的安全性。
Front Endocrinol (Lausanne). 2021 Jul 7;12:645563. doi: 10.3389/fendo.2021.645563. eCollection 2021.
7
Global Prevalence of Diabetic Retinopathy and Projection of Burden through 2045: Systematic Review and Meta-analysis.全球糖尿病视网膜病变的患病率及 2045 年预期负担的系统评价和荟萃分析。
Ophthalmology. 2021 Nov;128(11):1580-1591. doi: 10.1016/j.ophtha.2021.04.027. Epub 2021 May 1.
8
Cell-Subtype-Specific Remodeling of Intrinsically Photosensitive Retinal Ganglion Cells in Streptozotocin-Induced Diabetic Mice.糖尿病诱导的 STZ 小鼠中内在光敏感视网膜神经节细胞的细胞亚型特异性重塑。
Diabetes. 2021 May;70(5):1157-1169. doi: 10.2337/db20-0775. Epub 2021 Feb 11.
9
Comparing the use of individual and composite terms to evaluate adverse drug event disproportionality: a focus on glucagon-like peptide-1 receptor agonists and diabetic retinopathy.比较使用单个术语和复合术语评估药物不良事件的不均衡性:以胰高血糖素样肽-1受体激动剂和糖尿病视网膜病变为重点。
Expert Opin Drug Saf. 2021 Apr;20(4):475-480. doi: 10.1080/14740338.2021.1887136. Epub 2021 Mar 26.
10
HbA Change and Diabetic Retinopathy During GLP-1 Receptor Agonist Cardiovascular Outcome Trials: A Meta-analysis and Meta-regression.GLP-1 受体激动剂心血管结局试验中 HbA 变化与糖尿病视网膜病变:荟萃分析和荟萃回归。
Diabetes Care. 2021 Jan;44(1):290-296. doi: 10.2337/dc20-1815.